Article · 28 Oct 2025
Review articlePublished 7 Jul 2016
New developments to optimize postprandial glucose control with insulin in patients with diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Many patients with Type 1 or insulin-requiring Type 2 diabetes fail to achieve the widely recommended glycemic target of HbA1c below 7%. Insufficient control of postprandial glucose excursion plays an important role in this failure. The pharmacological profile of rapid-acting insulin analogs is still far from mimicking the physiological profile of endogenous insulin secretion. Several products are under development that aim to bring this goal closer. These developments include the use of jet injectors for insulin administration, coadministration of hyaluronidase, insulin agents that are resistant to hexamer formation, and insulin products that use an alternative route of administration. This review provides an overview of recent developments and discusses potential benefits with respect to postprandial glucose control.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Diabetes Management.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDiabetes Management
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Bastiaan E de Galan”